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http://dx.doi.org/10.1016/j.stemcr.2016.03.007SUMMARYContact with the extracellular matrix is essential for maintenance of epithelial cells in many tissues, while in its absence epithelial
cells can detach and undergo anoikis. Here, we show that anoikis of luminal cells in the prostate epithelium is followed by a program
of tissue repair that is mediated in part by differentiation of basal epithelial cells to luminal cells. We describe a mouse model in
which inducible deletion of E-cadherin in prostate luminal cells results in their apoptotic cell death by anoikis, in the absence of
phenotypic effects in the surrounding stroma. Quantitative assessments of proliferation and cell death in the luminal and basal
compartments indicate that basal cells can rapidly generate luminal cells. Thus, our findings identify a role for basal-to-luminal dif-
ferentiation in prostate epithelial repair, and provide a normal context to analogous processes that may occur during prostate cancer
initiation.INTRODUCTION
Epithelial integrity and tissue homeostasis are severely
challenged by wounding or a range of pathological
states. Under such conditions, epithelial cells can detach
from the underlying basement membrane and undergo
apoptotic cell death through a process known as anoikis
(Chiarugi and Giannoni, 2008; Frisch and Francis, 1994;
Frisch and Screaton, 2001; Taddei et al., 2012). Subse-
quently, the missing epithelial cells can be replaced
through the activity of endogenous stem/progenitor
cells. In the prostate, insults such as bacterial or viral
infection can result in inflammation and epithelial cell
death, but the process of repair has been poorly studied
to date.
The identity of epithelial stem/progenitor cells within
the prostate remains a subject of intense study (Shibata
and Shen, 2015). The prostate epithelium comprises
luminal, basal, and neuroendocrine cells, with both
luminal and basal compartments containing stem/pro-
genitor activity (Shen and Abate-Shen, 2010). In addi-
tion, rare ‘‘intermediate’’ cells that co-express basal and
luminal markers have been proposed to correspond to
stem/progenitor cells (De Marzo et al., 1998; Verhagen
et al., 1988; Wang et al., 2001; Xue et al., 1998), or a tran-
sitional state between basal progenitors and luminal de-
scendants (Bonkhoff and Remberger, 1996; Litvinov
et al., 2006; Ousset et al., 2012; van Leenders et al.,
2000).
Stem/progenitor activity has been observed in distinct
contexts during prostate development and homeostasis
in vivo. In the hormonally naive adult prostate epithelium,660 Stem Cell Reports j Vol. 6 j 660–667 j May 10, 2016 j ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://creativluminal and basal compartments are maintained by unipo-
tent progenitors (Choi et al., 2012; Lu et al., 2013; Wang
et al., 2013), while during prostate organogenesis some
basal progenitors are multipotent, giving rise to luminal
and neuroendocrine progeny (Ousset et al., 2012; Wang
et al., 2014a). In addition, rare bipotential populations
exist within both the luminal and basal compartments dur-
ing androgen-mediated regeneration of the regressed pros-
tate (Lee et al., 2014; Wang et al., 2009, 2013, 2015).
In contrast, both luminal and basal populations display
considerable lineage plasticity in specific contexts. Ex-
planted luminal cells can generate basal cells in organoid
culture (Chua et al., 2014; Karthaus et al., 2014), whereas
basal cells can generate luminal cells in sphere formation
assays, and after recombinationwith embryonic urogenital
mesenchyme in renal grafts (Burger et al., 2005; Goldstein
et al., 2008, 2010; Hofner et al., 2015; Lawson et al., 2007;
Richardson et al., 2004; Wang et al., 2013). Basal-to-
luminal differentiation can also occur in pathological con-
texts, such as during prostate cancer initiation (Choi et al.,
2012; Lu et al., 2013; Wang et al., 2013, 2014b), and after
acute inflammation in bacterial prostatitis (Kwon et al.,
2014b).
Taken together, these findings indicate that basal-to-
luminal differentiation can occur in prostate organogen-
esis, pathogenesis, and ex vivo assays, but rarely during
normal tissue homeostasis. Thus, it has been unclear to
what extent the plasticity of endogenous adult prostate
basal cells in ex vivo models and disease states reflects an
in vivo activity. In this study, we introduce a mouse model
in which a tamoxifen-inducible Cre driver is used to delete
E-cadherin in prostatic luminal cells, which are highlyrs
ecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Inducible Deletion of E-Cadherin in the Prostate Epithelium
(A) Schematic timeline of the experiment.
(B–G) H&E staining of histological sections from the anterior prostate. Arrows in (C) show patches of atypical cells, and arrows in (D), (E),
and inset in (E) show cells sloughing into the lumen in Cdh1del prostates.
(H–M) Immunofluorescence staining for E-cadherin and YFP. Arrows in (H) show intact E-cadherin expression in control mice; arrows in (I),
(J), (K), and (M) show E-cadherin loss in YFP+ cells of Cdh1del prostates; and arrows in (L) indicate rare YFP+ cells in which E-cadherin was
not deleted.
(N–S) Immunofluorescence staining for p120 catenin and YFP. Arrows in (O), (P), and (Q) show cytoplasmic p120 staining in YFP+ cells of
Cdh1del prostates.
Numbers of mice examined: n = 7 for (B), (E), (H), (K), (N), and (Q); n = 5 for (C), (I), and (O); n = 4 for (D), (F), (G), (J), (L), (M), (P), (R),
and (S). Scale bars, 50 mm. See also Figures S1 and S2; Tables S1 and S2.susceptible to anoikis (Kwon et al., 2014a). This results in
rapid sloughing and death of luminal cells, followed by
repair of the damaged epithelium. We show that basal-to-
luminal differentiation contributes to tissue repair, pro-
viding a new approach for studying prostate stem/progen-
itor activity and epithelial specification.RESULTS
E-Cadherin Is Essential for Maintenance of Prostate
Luminal Cells
To delete E-cadherin (Cdh1) in the prostate epithelium, we
used mice carrying the tamoxifen-inducible Nkx3.1CreERT2
driver (Wang et al., 2009), the conditional Cdh1flox
allele (Boussadia et al., 2002), and an R26R-YFP reporter
(Srinivas et al., 2001). We administered tamoxifen toNkx3.1CreERT2/+ or CreERT2/CreERT2; Cdh1flox/flox; R26R-YFP
(designated Cdh1del) mice at 8 weeks of age, and analyzed
prostate tissues at 5, 9, 14, 20, and 30 days thereafter (Fig-
ure 1A). In parallel, control Nkx3.1CreERT2/+; R26R-YFP
mice were treated with tamoxifen and analyzed at 5, 14,
and 30 days later.
Histological analyses of the anterior prostate lobes
showed that controlsmaintained a normal phenotype after
tamoxifen treatment (Figures 1B, S1A, and S1B), whereas
Cdh1del prostates underwent epithelial damage and repair.
At 5 days after tamoxifen administration, we observed
foci of atypical cells in Cdh1del prostates (Figure 1C), and
at 9 and 14 days after tamoxifen treatment, many cells
had detached from the epithelium and were present in
the lumen (Figures 1D and 1E). However, by 20 days after
treatment, fewer detached cells were observed, and at
30 days the normal epithelial phenotype was restoredStem Cell Reports j Vol. 6 j 660–667 j May 10, 2016 661
(Figures 1F and 1G). Similar results were observed in the
ventral prostate (VP) and dorsolateral prostate (DLP) of
control and Cdh1del mice (Figure S2).
To confirm these phenotypes were due to E-cadherin
deletion, we analyzed co-expression of E-cadherin and
YFP by immunofluorescence staining of control and
Cdh1del prostates. In control prostates, E-cadherin dis-
played intact membrane localization in YFP+ cells (Figures
1H, S1C, and S1D). However, YFP+ cells in Cdh1del mice
started to lose E-cadherin expression by 5 days after tamox-
ifen treatment (Figure 1I), and was lost in 93% of YFP+ cells
at 9 days (Figure 1J and Table S1). Moreover, the detached
cells in the prostate lumen of Cdh1del mice at 14 and
20 days after treatment expressed YFP, but not E-cadherin
(Figures 1K and 1L). In contrast, by 30 days the epithelium
displayed a normal distribution of membrane-localized
E-cadherin, but YFP+ cells were nearly absent (Figure 1M).
Notably, the few remaining YFP+ cells were localized to
basal positions, comprising approximately 2% of the pros-
tate epithelium (Figure 1M and Table S2).
To confirm deletion of E-cadherin we also examined
expression of p120 catenin, a binding partner of E-cadherin
that becomes localized to the cytoplasm following loss of
E-cadherin (Shibamoto et al., 1995). Consistent with E-cad-
herin expression, control prostates displayed normalmem-
brane localization of p120 catenin (Figures 1N, S1E, and
S1F), whereas Cdh1del prostates at 5 days after tamoxifen
treatment contained sporadic luminal cells with increased
cytoplasmic localization of p120 (Figure 1O). At 9 and
14 days, numerous luminal cells showed strong cyto-
plasmic localization of p120 (Figures 1P and 1Q), which
were reduced in frequency at 20 days (Figure 1R). By
30 days, the Cdh1del prostates showed essentially normal
p120 expression, with rare cells that displayed cytoplasmic
p120 localization still detectable (Figure 1S).
E-Cadherin Deletion in Luminal Cells Results in
Anoikis Followed by Rapid Epithelial Repair
We anticipated that E-cadherin deletion would be limited
to the luminal compartment in Cdh1del prostates, since
the Nkx3.1CreERT2 driver is mostly restricted to luminal
cells (Wang et al., 2009). To examine the specificity of
E-cadherin deletion, we compared expression of YFP with
specific luminal and basal markers in control and Cdh1del
prostates at the most prominent stage of epithelial damage
(14 days), and after repair (30 days). As expected, YFP
expression was predominantly observed in CK18-positive
luminal cells of control mice at 30 days (34.9% of CK18+
cells versus 0.7% of CK5+ cells) (Figure 2A and Table S3).
In Cdh1del prostates, the detached YFP+E-cadherin– cells
in the prostate lumen at 14 days were also CK18+ (Fig-
ure 2B), confirming that these sloughed cells were luminal.
Notably, at 30 days the Cdh1del luminal cells displayed662 Stem Cell Reports j Vol. 6 j 660–667 j May 10, 2016membrane-localized E-cadherin but were YFP– (Figure 2C),
indicating replacement of sloughed luminal cells by newly
formed luminal cells.
However, at 30 days we observed rare surviving YFP+ cells
that occupied basal positions, but did not resemble normal
basal cells (Figure 2C); these may correspond to Cdh1 null
luminal cells that survived due to their ectopic localization.
Consistent with this interpretation, these residual YFP+
cells weremostly negative for the basalmarker CK5 (Figures
2D–2F and S3A; Table S2). Furthermore, the residual YFP+
cells were rarely intermediate (CK5+CK8+), did not express
the neuroendocrine marker synaptophysin, and did not
express N-cadherin, suggesting that they were not under-
going an epithelial-mesenchymal transition (Figures S3B–
S3D and Table S2).
Since deletion of E-cadherin resulted in sloughing of
luminal cells, we examined whether these cells underwent
anoikis. We found that the apoptotic marker cleaved cas-
pase-3 (CC3) was rarely detected in control or Cdh1del pros-
tates at 30 days, but was readily detectable in the detached
luminal cells ofCdh1del prostates at 14 days (Figures 2G–2I).
Taken together, these data indicate that E-cadherin is essen-
tial for survival of luminal epithelial cells, and the Cdh1del
mice provide a model for studying anoikis and epithelial
repair in the prostate.
Loss of E-Cadherin in Prostate Luminal Cells Does Not
Affect the Surrounding Stroma
Since another model of prostate epithelial repair has sug-
gested a role for reactive stroma (Kwon et al., 2014b), we
examined whether epithelial deletion of E-cadherin might
result in stromal defects. Previous studies have character-
ized reactive stroma as displaying loss of smooth muscle-
expressing a-actin and an increase in fibroblasts that
express vimentin (Kwon et al., 2014b; Tuxhorn et al.,
2001; Tuxhorn et al., 2002). Therefore, we compared the
expression of smooth muscle a-actin (SMA) and vimentin
in control and Cdh1del prostates. Immunostaining of SMA
in control and Cdh1del prostates showed continuous
smooth muscle bands surrounding the epithelial ducts,
with no loss of smooth muscle organization (Figures 2J–
2L). In addition, we did not observe an increase in vimen-
tin staining in the stroma of Cdh1delmice (Figures 2M–2O),
indicating that the process of epithelial repair occurs
without a phenotypically reactive stroma.
Prostate Basal Cells Contribute to Epithelial Repair
after E-Cadherin Deletion in Luminal Cells
Next, we investigated the cell type(s) that were responsible
for epithelial repair in Cdh1del prostates. First, we quanti-
tated the proportion of basal (CK5+), luminal (CK8+), and
intermediate (CK5+CK8+) cells during tissue repair (Table
S4). We found that the proportions of basal and luminal
Figure 2. Deletion of E-Cadherin in Pros-
tate Luminal Cells Results in Anoikis
without Reactive Stroma
(A–C) Immunofluorescence staining of
anterior prostate for CK18, E-cadherin, and
YFP; arrows show CK18 expression in YFP+
cells.
(D–F) Immunofluorescence staining for
CK5, E-cadherin, and YFP; arrows show that
YFP+ cells do not express CK5.
(G–I) Immunofluorescence staining for
CK18 and cleaved caspase-3 (CC3). The
arrow in (H) shows co-localization of CC3
and CK18 in a sloughed cell; inset in (H)
shows co-localization of CC3 (red) and YFP
(green).
(J–L) Immunohistochemical staining for
smooth muscle a-actin shows normal
appearance of smooth muscle in control and
Cdh1del prostates (arrows).
(M–O) Immunohistochemical staining for
vimentin shows nearly undetectable ex-
pression in control and Cdh1del prostates.
Numbers of mice examined: n = 3 for (A),
(C), (D), (F), (G), (I), (J), (L), (M), and (O);
n = 4 for (B), (E), (H), (K), and (N).
Scale bars, 50 mm. See also Figure S3 and
Table S3.cells showed a significant increase and decrease respec-
tively, by 14 days, which then revert to normal proportions
by 30 days (Figures 3A–3F, 3M, and 3N). Notably, while
control prostates contained only rare intermediate cells,
Cdh1del prostates showed increasing proportions of inter-
mediate cells by 14 days, which subsequently decreased
to normal levels by 30 days (Figures 3A–3F and 3O). Inter-
estingly, we observed intermediate cells appearing to
emerge from the basal layer at 9 days (Figure 3C).
Second, we determined the percentages of proliferating
and detaching (dying) cells in the basal and luminal
compartments (Table S5). In control prostates, there was
limited epithelial proliferation that primarily occurred in
the luminal compartment (Figures 3G and 3P). However,in Cdh1del prostates, CK5+ basal cells showed significantly
increased proliferation at 9 and 14 days, before decreasing
to control levels (Figures 3H–3L and 3P), while little cell
death in basal cells was detected at any time point (Fig-
ure 3Q). We also found increased proliferation of luminal
cells at later time points (14 and 20 days), before decreasing
to control levels (Figures 3H–3L and 3P). Notably, cell death
as indicated by detachment into the lumen was only
detectable for CK8+ luminal cells, and was most significant
at 14 days (Figure 3Q).
Since the proportion of basal cells returned to normal
levels by 30 days, and few if any basal cells underwent anoi-
kis (Figures 3M and 3Q), the increased proliferation of basal
cells observed by 9 days (Figure 3P) indicates that basal cellsStem Cell Reports j Vol. 6 j 660–667 j May 10, 2016 663
Figure 3. Basal Cells Contribute to Epithelial Repair following E-Cadherin Deletion
(A–F) Immunofluorescence staining for CK5 and CK8 identifies double-positive intermediate cells (arrows).
(G–L) Immunofluorescence staining for CK8, CK5, and Ki67 shows low levels of proliferation in luminal (arrows) and basal (arrowheads)
cells of control and Cdh1del prostates.
(M–O) Quantitation of the proportions of basal (M), luminal (N), and intermediate (O) cells in control and Cdh1del prostates. Values
represent the mean and SD of at least three animals per group.
(P and Q) Quantitation of cell proliferation (P) and cell death (Q) in the basal and luminal compartments. Values represent the mean and SD
(error bars) of at least three animals per group.
Numbers of mice examined: n = 4 for (A), (B), (C), (E), (G), (H), (I), and (K); n = 5 for (D) and (J); n = 3 for (F) and (L). Scale bars, 50 mm.
See also Tables S4 and S5.contribute to repair of the luminal compartment. This
interpretation is also consistent with the transient increase
in the percentage of intermediate cells at 14 days (Fig-
ure 3O). Thus, our findings suggest that prostate basal cells
repair the luminal compartment by undergoing differenti-
ation into intermediate cells and then luminal cells, as sug-
gested by the increase in luminal proliferation after basal
proliferation.DISCUSSION
Our studies have shown that E-cadherin plays an essential
role in the maintenance of prostate epithelial integrity and
are consistent with the requirement for E-cadherin in ho-
meostasis of other epithelial tissues. For example, deletion
of E-cadherin in the mouse small intestine and uterus
in vivo leads to increased apoptosis and abnormal differen-
tiation, underscoring its essential role in maintenance of
epithelial architecture and function (Reardon et al., 2012;
Schneider et al., 2010). Similarly, we have found that dele-664 Stem Cell Reports j Vol. 6 j 660–667 j May 10, 2016tion of E-cadherin in prostate luminal cells results in their
sloughing into the prostate lumen followed by anoikis. Af-
ter loss of luminal cells, the prostate epithelium is repaired
by the activity of basal progenitors, likely by differentiation
through a transitional ‘‘intermediate cell’’ state, together
with activated luminal progenitors.
Notably, this process of tissue repair differs from
androgen-mediated regeneration of the regressed prostate,
which is largely driven by unipotent luminal and basal pro-
genitors, with contributions from bipotential luminal and
basal stem/progenitor cells (Choi et al., 2012; Liu et al.,
2011; Lu et al., 2013; Wang et al., 2009, 2013, 2015).
Such differences in progenitor behavior may reflect the
severity of tissue ‘‘damage’’ (Figure 4). Overall, we propose
that the identity of stem/progenitor cells depends upon
the tissue context, and that there is no single cell popula-
tion that can account for all stem cell properties within
the prostate epithelium.
Unlike other known contexts in which adult prostate
basal cells can generate luminal cells, the surrounding
stromal tissue is not profoundly affected in our epithelial
Figure 4. Assay Dependence of Stem/Progenitor Activity in the Prostate Epithelium
Schematic depiction of tissue repair and androgen-mediation regeneration of the prostate epithelium; newly generated cells are indicated
by different colors. During tissue repair, luminal epithelial cells are primarily generated by a process of basal proliferation and basal-to-
luminal differentiation in which ‘‘intermediate’’ cells represent a transitional state; in addition, there is activity of unipotent luminal
progenitors. During androgen-mediated regeneration, tissue growth is largely mediated by unipotent luminal and basal progenitors, with a
significant contribution by bipotential luminal stem cells (castration-resistant Nkx3.1-expressing cells [CARNs]).repair model. For example, basal-to-luminal differentia-
tion occurs in sphere formation assays in the absence of
stromal tissue, as well as in tissue recombinant grafts
with heterologous inductive mesenchyme (Burger et al.,
2005; Goldstein et al., 2008, 2010; Hofner et al., 2015;
Lawson et al., 2007; Richardson et al., 2004; Wang et al.,
2013). Furthermore, a model of bacterial prostatitis also
displays acute inflammation and stromal reactivity,
which was suggested to be responsible for altered basal
cell properties (Kwon et al., 2014b). These previous obser-
vations were consistent with the notion that the stroma
represents an important niche for basal progenitors.
In contrast, basal-to-luminal differentiation occurs in
our E-cadherin deletion model when there is no alteration
of the surrounding stroma, suggesting that there are sig-
nals intrinsic to the prostate epithelium that can promote
basal cells to participate in tissue repair. It will be inter-
esting in future studies to determine the identity of
such signals that activate basal cell proliferation and
differentiation.
Our findings potentially reconcile studies of prostate
epithelial stem/progenitor activity with work on injury/
repair models in other epithelial tissues (Blanpain and
Fuchs, 2014). For example, basal cells can form luminalsecretory and ciliated cell types in the lung airway epithe-
lium after treatment with noxious chemicals (Hogan
et al., 2014), and basal cells in the bladder urothelium
can generate intermediate and luminal umbrella cells after
bacterial or chemical injury (Shin et al., 2011). Thus, our
findings contribute to a unifying perspective for a role of
basal cells in injury repair of a range of epithelial tissues.
Finally, we suggest that the inherent plasticity of prostate
basal cells that can be observed in pathological conditions
and in cancer reflects latent progenitor activity that nor-
mally functions in tissue repair.EXPERIMENTAL PROCEDURES
Mouse Procedures
Experiments using mice were performed according to protocols
approved by the Institutional Animal Care and Use Committee
at Columbia University Medical Center. The Nkx3.1CreERT2 allele
was generated previously in our laboratory (Wang et al., 2009),
the Cdh1flox allele was obtained from the Jackson Laboratory
Induced Mutant Resource (B6.129-Cdh1tm2Kem/J) (Boussadia et al.,
2002), and the R26R-YFP reporter (Srinivas et al., 2001) was kindly
provided by Dr. Frank Costantini. For induction of Cre activity,
tamoxifen (Sigma catalog #T5648) dissolved in corn oil wasStem Cell Reports j Vol. 6 j 660–667 j May 10, 2016 665
introduced by oral gavage (40 mg/kg) for 4 consecutive days to
mice at 2–3 months of age. See also Supplemental Experimental
Procedures.
Histology and Immunostaining
Individual prostate lobes were fixed in 10% formalin followed
by paraffin embedding, and immunostaining was performed on
5-mm sections. H&E staining was performed using standard proto-
cols. See also Supplemental Experimental Procedures.
Quantitation and Statistical Analyses
For quantitation of immunofluorescence staining, 633 images
from a Leica TCS2 AOBS spectral confocal microscope were used
for manual counting of the number of cells with the indicated
expression patterns. For statistical comparisons in Figure 3, per-
centages were analyzed by an unpaired t test or one-way ANOVA
and Dunnett’s multiple comparison test using Prism 6 software
(GraphPad).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and five tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2016.03.007.
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